Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Ann Hematol ; 2024 Mar 06.
Article in English | MEDLINE | ID: mdl-38448787

ABSTRACT

BACKGROUND: The roles of Lenalidomide (Len) and Daratumumab (Dara) in multiple myeloma treatment are well-established, yet their influences on hematopoietic stem cell harvesting and reconstitution remain disputed. METHODS: We conducted a systematic database review to identify cohort studies or RCTs evaluating the effect of the use of Len or Dara on hematopoietic stem cell collection and peripheral blood count recovery in multiple myeloma patients. Effects on hematopoietic collection or reconstitution were estimated by comparing standardized mean differences (SMD) and mean differences (MD), or median differences. RESULTS: Eighteen relevant studies were identified, summarizing mobilization results. For Len, data from 13 studies were summarized, including total CD34+ cell yield, collection failure rate, and time to neutrophil and platelet engraftment. Results indicated that Len exposure led to decreased stem cell collection [SMD=-0.23, 95% CI (-0.34, -0.12)]. However, collection failure (<2×106) could be mitigated by plerixafor [OR=2.14, 95% CI (0.96, 4.77)]. For Dara, two RCTs and three cohort studies were included, showing that Dara exposure resulted in a reduction in total stem cells even with optimized plerixafor mobilization [SMD=-0.75, 95% CI (-1.26, -0.23)], and delayed platelet engraftment recovery [MD=1.20, 95% CI (0.73, 1.66)]. CONCLUSIONS: Our meta-analysis offers a comprehensive view of Len and Dara's impacts on hematopoietic stem cell collection and reconstitution in multiple myeloma. Len usage could lead to reduced stem cell collection, counteracted by plerixafor mobilization. Dara usage could result in diminished stem cell collection and delayed platelet engraftment.

2.
BMC Public Health ; 23(1): 326, 2023 02 14.
Article in English | MEDLINE | ID: mdl-36788527

ABSTRACT

BACKGROUND: Advanced maternal age (AMA; ≥35 years) is considered to be a major risk factor for adverse pregnancy outcomes. Along with the global trend of delayed childbearing, and in particular, the implementation of China's second and third-child policy leading to a dramatic increase of AMA in recent years, the association between maternal age and pregnancy outcomes requires more investigation. METHODS: A population-based retrospective study was performed. Data were derived from the Medical Birth Registry of Xiamen from 2011 to 2018. Univariate and multivariate logistic regression was used to evaluate the effects of maternal age on pregnancy outcomes. RESULTS: A total of 63,137 women categorized into different age groups (< 25 years, 25-29 years, 30-34 years, and ≥ 35 years) were included in this study. Compared with the mothers aged 25-29 years, the univariate regression analysis showed that mothers aged < 25 years had lower risks of gestational diabetes mellitus (GDM) and cesarean. AMA was associated with higher risks of GDM, hypertension, cesarean, preterm birth, low-birth weight (LBW), large-for-gestational-age (LGA), macrosomia, and stillbirth (all P < 0.01). After adjustment for potential confounding factors, increased risks of GDM, hypertension, cesarean, preterm birth, and LBW remained significantly associated with AMA (all P < 0.05), whereas AMA mothers showed a lower risk of macrosomia than their younger counterparts. Additionally, no significant differences were detected in terms of Apgar score < 7. CONCLUSION: AMA was associated with adverse pregnancy outcomes including increased risks of GDM, hypertension, cesarean, preterm birth, and LBW. This study confirmed the relationship between AMA and certain adverse maternal and fetal outcomes and emphasizes the necessity for women to be cautious about the age at which they become pregnant.


Subject(s)
Diabetes, Gestational , Hypertension , Premature Birth , Pregnancy , Infant, Newborn , Female , Humans , Pregnancy Outcome/epidemiology , Retrospective Studies , Fetal Macrosomia , Premature Birth/epidemiology , Diabetes, Gestational/epidemiology , Maternal Age , Risk Factors , Weight Gain , China/epidemiology
3.
Diabetes Ther ; 14(1): 167-178, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36454378

ABSTRACT

INTRODUCTION: Patients with diabetes are confronted with numerous obstacles to achieve adequate glycemic control during hospitalization. The aim of this study was to explore the risk factors associated with glycemic control in hospitalized patients with type 2 diabetes mellitus (T2DM) treated with continuous subcutaneous insulin infusion (CSII). METHODS: This cross-sectional study included 5223 patients hospitalized with T2DM in a tertiary hospital in Xiamen (China) between January 2017 and December 2019. All patients were managed according to established protocols for glycemic monitoring and insulin pump treatment regimens. Demographic information and clinical profiles were collected from electronic health records. Multiple linear regression analysis was used to identify the risk factors associated with glycemic control. RESULTS: Among the 5223 hospitalized patients with T2DM receiving CSII therapy, 55.2% achieved their ideal blood glucose level (3.9-10.0 mmol/L), 44.5% experienced hyperglycemia (> 10.0 mmol/L), and 0.3% experienced hypoglycemia (< 3.9 mmol/L) during their hospitalization. Multivariate analyses showed that among inpatients with T2DM, older age, male gender, higher low-density lipoprotein-cholesterol (LDL-C) level, lower C-peptide (C-P) level, lower body mass index (BMI), longer duration of diabetes, previous insulin prescriptions, nephropathy, and retinopathy were factors more likely to be associated with a blood glucose level in the hyperglycemic range (P < 0.05). We also observed that among hospitalized patients with T2DM, those with lower BMI, lower C-P, lower LDL-C, longer disease duration, and previous insulin prescriptions were more likely to correlate with a higher proportion of hypoglycemia range (all P < 0.05). CONCLUSION: Older age, male gender, lower BMI, lower C-P, higher LDL-C, previous insulin prescriptions, longer duration of diabetes, nephropathy, and retinopathy may be risk factors for a higher proportion of hyperglycemic events in hospitalized patients with T2DM under CSII therapy. Furthermore, lower BMI, lower C-P, lower LDL-C, longer duration of diabetes, and previous insulin prescriptions were found to be important factors for a higher proportion of hypoglycemic events. Evaluating the clinical features, comorbidities, and complications of hospitalized patients is essential to achieve reasonable glycemic control.

4.
Diabetol Metab Syndr ; 14(1): 180, 2022 Nov 28.
Article in English | MEDLINE | ID: mdl-36443872

ABSTRACT

BACKGROUND: Patients with diabetes are prone to asymptomatic hypoglycemia (AH) due to diminished ability to perceive the onset of hypoglycemia. However, the actual prevalence and influencing factors of AH in outpatients with type 2 diabetes (T2DM) have not been well investigated. METHODS: A total of 351 outpatients with T2DM underwent glucose monitoring by continuous glucose monitoring system (CGMS) for consecutive 72 h without changing their lifestyle and treatment regimens. Hypoglycemia is defined as a blood glucose level less than 3.9 mmol/L, which was further divided into Level 1 hypoglycemia (blood glucose 3.0-3.9 mmol/L) and Level 2 hypoglycemia (blood glucose < 3.0 mmol/L). Univariate and multivariate logistic regression analyses were used to determine the possible risk factors of AH. RESULTS: In all 351 subjects studied, 137 outpatients (39.0%) were captured AH events, in which Level 1 AH and Level 2 AH accounted for 61.3% and 38.7%, respectively. 85 (62.0%) of the AH patients experienced nocturnal asymptomatic hypoglycemia (NAH) and 25 (18.2%) exclusively NAH. Multivariate logistic regression analysis demonstrated that patients with younger age, lower hemoglobin A1c (HbA1c), and higher systolic blood pressure (SBP) levels were associated with increased risk of AH. While after further grading of AH, male sex and Dipeptidylpeptidase-4 inhibitors (DPP4i) regime were shown to be associated with lower risk of Level 2 AH. CONCLUSIONS: Hypoglycemia unawareness could be frequently observed at either daytime or nighttime, although NAH was more common, in outpatients with T2DM. Relative relax HbA1c targets should be considered for patients who are prone to AH.

5.
Front Endocrinol (Lausanne) ; 13: 913207, 2022.
Article in English | MEDLINE | ID: mdl-35909561

ABSTRACT

Objective: Studies have shown that sex differences in lean mass, concentrations of sex hormones, and lifestyles influence cle health and glucose metabolism. We evaluated the sex-specific association between low muscle mass and glucose fluctuations in hospitalized patients with type 2 diabetes mellitus (T2DM) receiving continuous subcutaneous insulin infusion (CSII) therapy. Methods: A total of 1084 participants were included. Body composition was determined by dual-energy X-ray absorptiometry. Intraday blood glucose fluctuation was estimated by the Largest amplitude of glycemic excursions (LAGE) and standard deviation of blood glucose (SDBG). Results: The prevalence of low muscle mass was higher in males than in females (p<0.001). There was a significant sex-specific interaction between the status of low muscle mass and glucose fluctuations (LAGE and SDBG) (p for interaction=0.025 and 0.036 for SDBG and LAGE, respectively). Among males, low muscle mass was significantly associated with a higher LAGE and SDBG (difference in LAGE: 2.26 [95% CI: 1.01 to 3.51], p < 0.001; difference in SDBG: 0.45 [95% CI: 0.25 to 0.65], p < 0.001) after adjustment for HbA1c, diabetes duration, hyperlipidemia, diabetic peripheral neuropathy, diabetic nephropathy, and cardiovascular disease. These associations remained significant after further adjustment for age and C-peptide. Among females, low muscle mass was not associated with LAGE or SDBG after adjustment for all covariates. Conclusion: The prevalence of low muscle mass was higher in males than in females. Low muscle mass was significantly associated with higher LAGE and SDBG among males, but not females.


Subject(s)
Diabetes Mellitus, Type 2 , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/epidemiology , Female , Glucose , Humans , Insulin , Male , Muscles
6.
Front Immunol ; 12: 734685, 2021.
Article in English | MEDLINE | ID: mdl-34594339

ABSTRACT

APS (autoimmune polyglandular syndrome) is defined as the coexistence of at least two kinds of endocrine autoimmune diseases. APS type 3 comprises autoimmune thyroid diseases and other autoimmune diseases but does not involve autoimmune Addison's disease. So far, APS-3 combined with isolated gonadotropin-releasing hormone (GnRH) reduction caused by the suspected autoimmune hypothalamic disease has not been reported. We recently received a 43-year-old woman with a one-year history of Graves' disease (GD) and a four-month history of type 1 diabetes presented with hyperthyroidism and hyperglycemia. After the GnRH stimulation test, she was diagnosed with secondary amenorrhea attributed to suspected autoimmune Hypothalamitis and APS type 3 associated with Graves' disease and Latent Autoimmune Diabetes (LADA). According to this case, the hypothalamus cannot be spared from the general autoimmune process. It is recommended to carry out the GnRH stimulation test when encountering APS patients combined with secondary amenorrhea.


Subject(s)
Gonadotropin-Releasing Hormone/deficiency , Graves Disease/complications , Hypothalamic Diseases/complications , Latent Autoimmune Diabetes in Adults/complications , Polyendocrinopathies, Autoimmune/complications , Adult , Amenorrhea/diagnosis , Amenorrhea/etiology , Biomarkers/blood , Female , Gonadotropin-Releasing Hormone/blood , Graves Disease/blood , Graves Disease/diagnosis , Graves Disease/drug therapy , Humans , Hypothalamic Diseases/blood , Hypothalamic Diseases/diagnosis , Hypothalamic Diseases/drug therapy , Latent Autoimmune Diabetes in Adults/blood , Latent Autoimmune Diabetes in Adults/diagnosis , Latent Autoimmune Diabetes in Adults/drug therapy , Polyendocrinopathies, Autoimmune/blood , Polyendocrinopathies, Autoimmune/diagnosis , Polyendocrinopathies, Autoimmune/drug therapy
7.
Waste Manag ; 127: 130-140, 2021 May 15.
Article in English | MEDLINE | ID: mdl-33933870

ABSTRACT

Efficient waste separation using recycling bins designed appropriately is promising for waste recycles. This study investigated recycling bin designs, in particular color and insert slot, and quantified perceptive preferences toward designs. This study hypothesized that design preference toward recycling bins is affected by past perceptions of recycling bin designs. Design categorization survey for 240 recycling bins used in public spaces shows that popular colors depend on design items and waste types. This study found that highly preferred colors were consistent with frequently used colors in certain design items, which was slot frame color for combustible and incombustible waste bins, and body color for PET bottle bins. Color preferences had statistically significant correlations with color usage rates (p = 0.009 for combustible waste bin, p = 0.032 for incombustible waste bin, and p = 0.012 for PET bottle bin, respectively). Although insert slot shape had moderate but significant correlations between slot shape preference and usage rate of slot shape (p = 0.002 or less for all recycling bins), the preference was mainly affected by slot largeness for combustible and incombustible waste bins. According to these results, this study concludes that the hypothesis was supported in particular for color preference. On the other hand, on-site experiments showed that the effect of only "impressive" color was too weak to improve waste separation. To encourage waste sorting using well-designed recycling bins, combination of preferred design items is necessary. Intensive usage of well-designed recycling bins for frequent perception opportunities is recommended as an environmental feedback to support sufficient design preference.


Subject(s)
Refuse Disposal , Waste Management , Environment , Perception , Recycling
8.
Waste Manag ; 94: 58-67, 2019 Jul 01.
Article in English | MEDLINE | ID: mdl-31279396

ABSTRACT

This study investigated the effects of setting conditions of trash bins on waste collection, separation efficiency, and incorrect disposal. Tested trash bins are for combustible wastes, PET bottles, cans, and glass bottles. Monitoring results were analyzed by statistical tests to distinguish real effects and experimental errors. The distance to trash bins along walking path gave no significant effects on waste collection and the others. On the other hand, when the distance was out of walking path, its increase significantly decreased waste collection of combustible wastes. In contrast, the distance gave no significant effect on separation efficiency and foreign waste percentage. It was suggested that threshold distance that affects waste disposal behaviors is between 8 and 410 m. When trash bins were set separately, it affected the motivation of waste separations. Separated setting of combustible waste and PET bottle trash bins in the opposite side of the original position significantly decreased separation efficiencies of these wastes. Because no significant effect was found on separation efficiency of other wastes whose trash bins were set in the original position, additional 3 m distance to the opposite side might exceed the threshold distance and have caused low separation efficiencies. The preference of trash bin arrangement gave no significant effect on waste collection and the others excluding separation efficiency of can. These results suggest that appropriate location of trash bins can improve waste collection and waste separation. It might be useful for waste management in public areas with high population density like shopping mall.


Subject(s)
Garbage , Refuse Disposal , Waste Management , Environment , Walking
9.
Waste Manag ; 95: 32-42, 2019 Jul 15.
Article in English | MEDLINE | ID: mdl-31351618

ABSTRACT

Many municipalities in Japan have collected PET bottles as recyclable waste since 1980s. When caps are removed from bottles, it reduces collection and transportation costs because bottles can be easily compressed by collection trucks. However, PET bottles collected from recycling bins are usually capped and include other materials. This study designed 10 recycling bins for PET bottle to investigate the effect of design on cap removal efficiency and recycling contamination (foreign waste mixture). Recycling bins for PET bottle were designed focusing on four design items. They are (1) individual recycling bins specifically for bottles and caps or all-in-one recycling bin for both bottle and cap collections, (2) inside-visibility (see-through), (3) signage (wording like "Bottle" and "Cap") near insert slot and (4) insert slot shape. PET bottle collection performance of designed recycling bins was monitored in Suzukakedai campus of Tokyo Tech. Perceptive preferences of recycling bin designs and insert slot shapes were measured by online surveys. Experimental results indicate that insert slot with round shape contributed to significantly lower recycling contamination than bottle-like shape although perceptive preference of insert slots with bottle-like shape was higher than that of the round shape. Signage and all-in-one design is significantly effective to promote cap removal only when it was set with other recycling bins. On the other hand, signage is effective to decrease recycling contamination in a single setting. This study found that design effect depended on the setting condition of recycling bins in terms of cap removal and foreign waste disposal.


Subject(s)
Recycling , Refuse Disposal , Cities , Japan , Tokyo
10.
Pak J Pharm Sci ; 27(4 Suppl): 1023-7, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25016261

ABSTRACT

This paper is mainly to study the influence of Glutamine's reinforcing role in enteral nutrition on postoperative nutrition and immune function of patients with gynecologic malignant tumor. The adopted method is through selecting 60 patients with gynecological malignant tumor, they are randomly divided into groups of enteral immune nutrition (EIN group) and conventional enteral nutrition (EN group), which are given enteral nutrition of equal nitrogen and heat respectively in postoperative 24 hours, the total period of nutritional support are 7 days. The research results represent that nutrition and immunity index in both groups on the first day after operation is lower than the day before operation, and all indicators have picked up on the ninth day after operation.


Subject(s)
Enteral Nutrition , Genital Neoplasms, Female/surgery , Glutamine/administration & dosage , Nutritional Support , Female , Genital Neoplasms, Female/immunology , Humans
11.
Int J Ophthalmol ; 5(3): 397-400, 2012.
Article in English | MEDLINE | ID: mdl-22773996

ABSTRACT

AIM: To explore the relationship between gene polymorphisms of vascular endothelial growth factor (VEGF) and retinopathy of prematurity (ROP). METHODS: Literature materials related to gene polymorphisms of VEGF and ROP in PubMed, EMBASE, Cochrane and CBM database were retrieved. These materials were screened according to inclusion and exclusion standards. Patients diagnosed with ROP in clinic were regarded as control group and ROP patients who were in treatment were regarded as observation group. The indexes in two groups were matched except birth weight (BW), gender and gestational weeks. Meta5.1 was used to analyze the relationship between gene polymorphisms of VEGF and ROP. RESULTS: Four random control tests (RCT) were included in this research, including 2611 patients. Meta analysis results showed that VEGF affected ROP, having statistical significance. The combined ratio was 0.44 (95%CI, 0.07, 0.80), 0.42 (95%CI, 0.09, 0.74) and 0.75 (95%CI, 0.02, 1.49), respectively. Carrying +405 allele might increase the premature infants' risk of having ROP. CONCLUSION: ROP may be related to its carrying of +405 allele. Large-scale, multi-factor RCT researches are still needed in order to identify the relation between VEGF and ROP.

12.
Biol Reprod ; 87(2): 29, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22572996

ABSTRACT

The objective was to explore the effects of metformin on the expression of endometrial glucose transporter 4 (GLUT4) and analyze the related factors of GLUT4 in patients with polycystic ovary syndrome (PCOS). This study included 20 obese patients with PCOS (PCOS group) and 20 obese patients who had infertility caused by oviducal or pelvic factors but had no PCOS (control group). Follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol-2 (E(2)), testosterone (T), fasting serum glucose (FSG), fasting insulin serum (FINS), homeostasis model assessment-insulin resistance (HOMA-IR), and endometrial GLUT4 expression were determined in the two groups. In PCOS group, patients were given 500 mg of metformin three times per day for 3 mo, and then the parameters above were determined again and compared with that before metformin treatment. The parameters above also were compared between PCOS and control groups. The correlation of GLUT4 with its related factors was analyzed. The levels of T, FINS, and HOMA-IR were higher in PCOS group than in the control group (P < 0.01). The levels of protein and mRNA of endometrial GLUT4 were lower in the PCOS group than in the control group (P < 0.001). The expression of protein and mRNA of endometrial GLUT4 increased after metformin treatment (P < 0.001). HOMA-IR was negatively correlated with GLUT4 expression (P = 0.027). In patients with PCOS, the levels of protein and mRNA of endometrial GLUT4 were lower compared with that in non-PCOS women, and HOMA-IR was strongly associated with endometrial GLUT4 expression. Metformin may up-regulate endometrial GLUT4 expression to improve endometrial IR.


Subject(s)
Endometrium/metabolism , Glucose Transporter Type 4/metabolism , Hypoglycemic Agents/therapeutic use , Metformin/therapeutic use , Obesity/complications , Polycystic Ovary Syndrome/drug therapy , Adult , Body Mass Index , Case-Control Studies , Female , Humans , Hypoglycemic Agents/pharmacology , Metformin/pharmacology , Obesity/metabolism , Polycystic Ovary Syndrome/complications , RNA, Messenger/metabolism , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...